Total Return chart Recce Pharmaceuticals Ltd

Stocks

Delayed Australian S.E. 10:40:10 28/10/2026 am IST			5-day change	1st Jan Change
0.3150 ^AUD	+1.61%		-10.00%	-51.54%

22/10	Recce Pharmaceuticals Signs Exclusive License Deal With Arrotex; Shares Fall 6%	MT
20/10	Recce Says Trial Data Review Shows 'Strong' Efficacy, Positive Safety Profile of Diabetic Foot Infection Drug Candidate; Shares Jump 16%	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.